Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398587
Status:
WITHDRAWN
Last Update Posted:
2024-05-03
First Post:
2024-04-30
Brief Title:
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
Organization:
OHSU Knight Cancer Institute